Pharmaceuticals, Biotechnology and Life Sciences
Oslo, September 11, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announced that…
InBrain Pharma announces the publication of an article on the pharmacokinetic and pharmacodynamic limitations of L-DOPA in the management…
AMSTERDAM, Sept. 11, 2024 (GLOBE NEWSWIRE) — (NASDAQ: RENB) The Board of Renovaro, Inc (RENB) intends to seek strategic investors…
Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Treatment of Subfertility and Recurrent Pregnancy LossSINGAPORE, Sept. 11, 2024…
Company is planning a follow-up clinical trial with a focused subject population of moderate-to-severe Post-COVID-related fatigueOCALA, Fla., Sept. 11, 2024…
SACRAMENTO, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) — Conception Nurseries, the industry leading biotech company and single largest cannabis plant…
LA JOLLA, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage…
Late-breaking data at WCLC show Libtayo monotherapy nearly doubled median overall survival and reduced the risks of death and disease…
If approved, neffy 1 mg will be the first and only needle-free epinephrine treatment available for younger school-aged children The…